Differentiation syndrome in patients with acute promyelocytic leukemia

<p dir="ltr">A 48‐year‐old male diagnosed with acute promyelocytic leukemia (APL) started on all‐trans‐retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, ne...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Nusiba H. Elamin (21385589) (author)
مؤلفون آخرون: Farah Rashid (13513911) (author), Muhammad S. Afana (21385592) (author), Honar Cherif (17746722) (author), Mohamed A. Yassin (8361183) (author)
منشور في: 2023
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513547845763072
author Nusiba H. Elamin (21385589)
author2 Farah Rashid (13513911)
Muhammad S. Afana (21385592)
Honar Cherif (17746722)
Mohamed A. Yassin (8361183)
author2_role author
author
author
author
author_facet Nusiba H. Elamin (21385589)
Farah Rashid (13513911)
Muhammad S. Afana (21385592)
Honar Cherif (17746722)
Mohamed A. Yassin (8361183)
author_role author
dc.creator.none.fl_str_mv Nusiba H. Elamin (21385589)
Farah Rashid (13513911)
Muhammad S. Afana (21385592)
Honar Cherif (17746722)
Mohamed A. Yassin (8361183)
dc.date.none.fl_str_mv 2023-01-26T09:00:00Z
dc.identifier.none.fl_str_mv 10.1002/ccr3.6697
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Differentiation_syndrome_in_patients_with_acute_promyelocytic_leukemia/29098499
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Cardiovascular medicine and haematology
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
acute leukemia
ATRA syndrome
steroids
dc.title.none.fl_str_mv Differentiation syndrome in patients with acute promyelocytic leukemia
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">A 48‐year‐old male diagnosed with acute promyelocytic leukemia (APL) started on all‐trans‐retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, needs to be monitored closely for developing differentiation syndrome and to start steroid upon suspicion.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/ccr3.6697" target="_blank">https://dx.doi.org/10.1002/ccr3.6697</a></p>
eu_rights_str_mv openAccess
id Manara2_f47bba00f6419c03f4257920a16a4cc7
identifier_str_mv 10.1002/ccr3.6697
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/29098499
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Differentiation syndrome in patients with acute promyelocytic leukemiaNusiba H. Elamin (21385589)Farah Rashid (13513911)Muhammad S. Afana (21385592)Honar Cherif (17746722)Mohamed A. Yassin (8361183)Biomedical and clinical sciencesCardiovascular medicine and haematologyOncology and carcinogenesisPharmacology and pharmaceutical sciencesacute leukemiaATRA syndromesteroids<p dir="ltr">A 48‐year‐old male diagnosed with acute promyelocytic leukemia (APL) started on all‐trans‐retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, needs to be monitored closely for developing differentiation syndrome and to start steroid upon suspicion.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/ccr3.6697" target="_blank">https://dx.doi.org/10.1002/ccr3.6697</a></p>2023-01-26T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/ccr3.6697https://figshare.com/articles/journal_contribution/Differentiation_syndrome_in_patients_with_acute_promyelocytic_leukemia/29098499CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/290984992023-01-26T09:00:00Z
spellingShingle Differentiation syndrome in patients with acute promyelocytic leukemia
Nusiba H. Elamin (21385589)
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
acute leukemia
ATRA syndrome
steroids
status_str publishedVersion
title Differentiation syndrome in patients with acute promyelocytic leukemia
title_full Differentiation syndrome in patients with acute promyelocytic leukemia
title_fullStr Differentiation syndrome in patients with acute promyelocytic leukemia
title_full_unstemmed Differentiation syndrome in patients with acute promyelocytic leukemia
title_short Differentiation syndrome in patients with acute promyelocytic leukemia
title_sort Differentiation syndrome in patients with acute promyelocytic leukemia
topic Biomedical and clinical sciences
Cardiovascular medicine and haematology
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
acute leukemia
ATRA syndrome
steroids